Undecided

[PL-2] Novel molecular pathogenesis and therapeutic target in acute erythroid leukemia

June Takeda¹, Leeyung Shih², Kenichi Chiba³, Yuichi Shiraishi³, Yusuke Shiozawa⁴, Tetsuichi Yoshizato¹, Ayana Kon¹, Yotaro Ochi¹, Yasunobu Nagata⁵, Akira Hangaishi⁶, Ken Ishiyama⁷, Hisashi Tsurumi⁸, Yasushi Miyazaki⁹, Nobuhiro Hiramoto¹⁰, Takayuki Ishikawa¹⁰, Akifumi Takaori¹¹, Keisuke Kataoka¹, Masashi Sanada¹², Hiroko Tanaka³, Kensuke Usuki⁶, Shuichi Miyawaki¹³, Satoru Miyano³, Arnold Ganser¹⁴, Michael Heuser¹⁴, Felicitas Thol¹⁴, Yasuhito Nanya¹, Kenichi Yoshida¹, Seishi Ogawa^1,15 (1.Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan, 2.Division of Haematology-Oncology, Chang Gung Memorial Hospital, Taoyuan, Taiwan, 3.Human Genome Centre, Institute of Medical Science, Tokyo, Japan, 4.Department of Paediatrics, The University of Tokyo, Japan, 5.Department of Translational Haematology, Cleveland Clinic, OH, United States, 6.Department of Haematology, NTT Medical Centre Tokyo, Tokyo, Japan, 7.Department of Haematology, Kanazawa University, Kanazawa, Japan, 8.Department of Hematology, Gifu University, Gifu, Japan, 9.Department of Hematology, Nagasaki University, Nagasaki, Japan, 10.Department of Hematology, Kobe City Medical Center General Hospital, 11.Department of Haematology / Oncology, Kyoto University, Kyoto, Japan, 12.National Hospital Organization Nagoya Medical Centre, Nagoya, Japan, 13.Division of Haematology, Tokyo Metropolitan Ohtsuka Hospital, Tokyo, Japan, 14.Department of Haematology, Hannover Medical School, Hannover, Germany, 15.Department of Medicine, Karolinska Institute, Sweden)